- Home
- GRI vs NUWE Comparison
GRI vs NUWE Comparison
Compare GRI & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- NUWE
- Stock Information
- Founded
- GRI 2018
- NUWE 1999
- Country
- GRI United States
- NUWE United States
- Employees
- GRI N/A
- NUWE N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GRI Health Care
- NUWE Health Care
- Exchange
- GRI Nasdaq
- NUWE Nasdaq
- Market Cap
- GRI 5.6M
- NUWE 5.2M
- IPO Year
- GRI N/A
- NUWE N/A
- Fundamental
- Price
- GRI $0.42
- NUWE $1.30
- Analyst Decision
- GRI Strong Buy
- NUWE Strong Buy
- Analyst Count
- GRI 2
- NUWE 1
- Target Price
- GRI $11.50
- NUWE $17.00
- AVG Volume (30 Days)
- GRI 172.9K
- NUWE 1.1M
- Earning Date
- GRI 03-27-2025
- NUWE 03-11-2025
- Dividend Yield
- GRI N/A
- NUWE N/A
- EPS Growth
- GRI N/A
- NUWE N/A
- EPS
- GRI N/A
- NUWE N/A
- Revenue
- GRI N/A
- NUWE $8,969,000.00
- Revenue This Year
- GRI N/A
- NUWE $2.18
- Revenue Next Year
- GRI N/A
- NUWE $25.75
- P/E Ratio
- GRI N/A
- NUWE N/A
- Revenue Growth
- GRI N/A
- NUWE 3.66
- 52 Week Low
- GRI $0.30
- NUWE $0.92
- 52 Week High
- GRI $12.31
- NUWE $26.95
- Technical
- Relative Strength Index (RSI)
- GRI 28.18
- NUWE 52.78
- Support Level
- GRI $0.43
- NUWE $1.17
- Resistance Level
- GRI $0.60
- NUWE $1.48
- Average True Range (ATR)
- GRI 0.06
- NUWE 0.09
- MACD
- GRI -0.00
- NUWE 0.01
- Stochastic Oscillator
- GRI 10.91
- NUWE 45.45
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.